Results

Total Results: 923 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

221. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - The burden of VTE is higher among some patient populations, including patients who have experienced … and safety of pharmacologic strategies for VTE prevention in patients with liver disease. … effectiveness and safety of pharmacologic strategies among patients with liver disease. … in the patient populations. … RCTs should evaluate the comparative effectiveness and safety of LMWHs in obese patients.

222. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
     February 01, 2018 - The workgroup suggests that EPC reviews focus on indicators of more severe harms (e.g., “serious” adverse … 9) How should input from technical and clinical experts and patients or patient advocacy groups be used … How should input from technical and clinical experts and patients or patient advocacy groups be used … Had to report data from groups of in which at least 85% of the patients were from one of the patient … What are the harms of therapeutic interventions for patients with ME/CFS and how do they vary by patient

223. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - IL-1 may be a problematic target with respect to safety in the gout patient population, however, and … and tolerability due to safety concerns over infections reported in trials thus far. … These safety concerns may present barriers to approval or barriers to diffusion if approved. … These safety concerns may present significant barriers to approval and diffusion if approved. … SLE: belimumab safety, efficacy sustained over 6 years. [internet].

224. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
     January 01, 2012 - the safety of teduglutide is likely to be required going forward … patient does not improve after 3 to 5 days, colectomy (i.e., surgical removal of the colon) can be … ) and should not require any major training or learning curve on the part of the patient. 5 … for treatment of short bowel syndrome These malignancies have been reviewed by an independent safety … A reduction in PN might significantly improve patient outcomes and quality of life.

225. new disposition of comments insulin analogues -- jda revs.xls (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
     September 01, 2008 - Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for  … Comparative  Effectiveness, Safety, and Indicuations of Insulin Analogues in Premixed Formulations for … information redacted] is pleased to submit comments on the Draft Report on Comparative Effectiveness, Safety … thank the AHRQ for the opportunity to comment on the draft report entitled Comparative Effectiveness, Safety … 6) Page 5 and in the Executive Summary consider adding item f to key question 1: Effectiveness and safety

226. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
     October 22, 2012 - may affect any particular patient. … adults and adolescents (≥14 years of age) and children (<14 years of age), what are the comparative safety … population is patients with chronic cough, included studies will need to define the patient population … The safety outcomes will be framed to help identify adverse events, including those from drug therapies … adults and adolescents (≥ 14 years of age) and children (< 14 years of age), what are the comparative safety

227. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - inclusion of this study further underscores the point that there is now substantial evidence of the safety … of this data would dominate the sample database upon which to draw definitive conclusions about the safety … Mark George Key Question 4 The report does not cite the most recent worldwide safety and side effect … and collapses across all modalities of ECT which obscures the clinical reality that the efficacy and safety … ever comes in contact with the patient or manipulates the data or data analysis.

228. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety, adverse events … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,d adverse events … Many of the studies reported limited data on patient characteristics, and black patients appeared to

229. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - As a clinician, I want to know how best to treat an individual patient with a defined subtype of JIA … One patient experiences a hematoma occurring on day 108 which was deemed unrelated to the study drug … Acute infusional adverse events were reported in one (2%) patient in the abatacept group and two (3% … All studies of safety were addressed in KQ3. … Of the 14 patients enrolled in the infliximab arm, 5 patients failed to complete 12 months – 4 because

230. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
     July 18, 2011 - Patient satisfaction with experience o Adverse effects of intervention(s) a. … Safety: RCTs, NRCTs, and prospective cohort studies. … Patient satisfaction with experience 8. … Exclusion of patients with comorbidities. … Dodick D, Lipton RB, Martin V, et al, for the Triptan Cardiovascular Safety Expert Panel.

231. Evidence Summary_Comparative Effectiveness Review No. 257: Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
     June 01, 2022 -  Barriers from both patient and provider perspectives: reduced visits may lead to important gaps …  Barriers from patient and provider perspectives: potential reduced quality of care with televisits …  Barriers from provider perspective: no or limited IT (information technology) literacy of patient … Concerns that televisits may hamper safety, quality of care, and worsen health disparities were noted … Further evidence on patient perspectives is needed from patients themselves (rather than from providers

232. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
     March 08, 2012 - of symptoms.2 However, the new scheme is not interchangeable with the traditional one, as different patient … Efficacy and safety beyond 3 weeks in patients with SAR have not been established.32 5. … The safety of intranasal decongestants during pregnancy has not been studied. … Outcomes must include patient-reported symptom scores and/or validated quality-of- life instruments; … for patients with mild symptoms.

233. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - patient safety and care … safety and care. … A diagnosis could, however, help patients and families plan for the patient’s care and safety. … Furthermore, experts thought that the drug’s well-known safety profile and long history of use (in … AD patients.

234. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - On the other hand, some thought that knowing that a patient has AD could aid planning in terms of safety … and care of the patient … and care of the patient. … A diagnosis could, however, aid patients and families in planning for the patient’s care and safety. … AD patients.

235. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - In patients with chronic plaque psoriasis, what is the comparative safety of systemic biologic agents … To be included, the patient population evaluated in the study must have been adult patients (≥18 years … In an RCT that compared the efficacy and safety of adalimumab with placebo in patients with moderate … Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate … Safety and efficacy study on etanercept in patients with plaque psoriasis.

236. AHRQ Slide Template 2019-Widescreen
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/mhs-IV-epc-grand-rounds-slides.pptx
     January 01, 2023 - safety and quality researchers; policymakers who work on patient safety and quality issues. 10 MHS … safety issues, and patient/consumer perspective. … safety subject matter experts within Penn Medicine and JHU’s Armstrong Institute for Patient Safety … , AHRQ’s Patient Safety Network (PSNet) website, the Joint Commission’s National Patient Safety Goals … , the National Quality Forum’s Patient Safety Report, and Becker’s Hospital Review 10 Top Patient Safety

237. Health-Careassociated-Infections Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_executive.pdf
     November 01, 2012 - safety practices:8 • Theory behind patient safety practice • Existing patient safety infrastructure … patient safety culture and teamwork at the unit level. … Safety Practice 9 3 4 0 16 Existing Patient Safety Infrastructure 8 6 2 4 20 External Factors 9 7 … Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient Safety Practices: … Advancing the science of patient safety. Ann Intern Med. 2011 May 17;154(10):693-6.

238. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
     March 29, 2011 - dopamine in the brain.16,17 Despite potential benefits, there is uncertainty about the efficacy and safety … of the long-term use of LNAAs and the target patient population, including the appropriateness of … with PKU that merit further study.5 Like pregnant women, safety and efficacy of the use of sapropterin … Primary outcomes in patient 1. … Primary outcomes in patient 1. Decreasing Phe levels in the blood 2.

239. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - data and postmarket safety evaluation, set forth by the U.S. … FDA expressed concerns about the long-term cardiovascular safety profile in the overweight and obese … Experts also opined that further studies evaluating efficacy and safety are needed. … quality of life, thus impacting patient health outcomes. … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.

240. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
     November 01, 2016 - acceptance is likely to be high because of the ease of administration and good 4 safety profile … A clinical study to evaluate the safety and efficacy of elagolix in subjects with moderate to severe … Study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate to severe … A global phase 3 study to evaluate the safety and efficacy of elagolix in subjects with moderate … Global study to evaluate the long-term safety and efficacy of elagolix in subjects with moderate